Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects

Prenatal Diagnosis

Volumn 29, Issue 6, 2009, Pages 570-577

  Jelliffe Pawlowski, Laura L ^a   Walton Haynes, Lynn ^a   Currier, Robert J ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Congenital heart defects; Down syndrome; Fetal imaging; Fetal ultrasound; Genetic counseling; Maternal serum screening; Screen positive

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; AORTA COARCTATION; ARTICLE; BIRTH DEFECT; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DOWN SYNDROME; ENDOCARDIAL CUSHION DEFECT; FALLOT TETRALOGY; FEMALE; FETUS; FETUS ECHOGRAPHY; GENETIC COUNSELING; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK PREGNANCY; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; MATERNAL SERUM; NEURAL TUBE DEFECT; NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; PATENT DUCTUS ARTERIOSUS; PREGNANCY OUTCOME; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; PULMONARY VALVE DISEASE; SECOND TRIMESTER PREGNANCY; TRICUSPID VALVE ATRESIA; TRICUSPID VALVE STENOSIS; TRISOMY 18;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOMES, HUMAN, PAIR 18; ESTRIOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SENSITIVITY AND SPECIFICITY; TRISOMY;

EID: 67049118179     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2239     Document Type: Article

References (26)

1. American Medical Association. 2008. International Classification of Diseases; Physician, Ninth Revision Clinical Modification. American Medical Association: Chicago.
2. Azar GB, Snijders RJ, Gosden C, Nicolaides KH. 1991. Fetal nuchal cystic hygromata: associated malformations and chromosomal defects. Fetal Diagn Ther 6(1-2): 46-57.
3. Barkehall-Thomas A, Tong S, Baker LS, Edwards A, Wallace EM. 2006. Maternal serum activin A and the prediction of intrauterine growth restriction. Aust N Z J Obstet Gynaecol 46(2): 97-101.
4. Bilardo CM, Muller MA, Zikulnig L, Schipper M, Hecher K. 2001. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 17(4): 288-294.
5. Bonnet D, Coltri A, Butera G, et al. 1999. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 99(7): 916-918.
6. Botto LD, Correa A, Erickson JD. 2001. Racial and temporal variations in the prevalence of heart defects. Pediatrics 107(3): E32.
7. Canfield MA, Honein MA, Yuskiv N, et al. 2006. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 76(11): 747-756.
8. Chervenak FA, Isaacson G, Blakemore KJ, et al. 1983. Fetal cystic hygroma. Cause and natural history. N Engl J Med 309(14): 822-825.
9. Craig WY, Haddow JE, Palomaki GE, et al. 2006. Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome. Prenat Diagn 26(9): 842-849.
10. Desgrosellier JS, Mundell NA, McDonnell MA, Moses HL, Barnett JV. 2005. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 280(1): 201-210.
11. Devore GR, Alfi O. 1993. The association between an abnormal nuchal skin fold, trisomy 21, and ultrasound abnormalities identified during the second trimester of pregnancy. Ultrasound Obstet Gynecol 3(6): 387-394.
12. Ganapathy R, Lamont RF, Bassett P. 2007. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome. Prenat Diagn 27(11): 995-999.
13. Honein MA, Kirby RS, Meyer RE, et al. 2008. The association between major birth defects and preterm birth. Matern Child Health J 13(2): 164-175.
14. Jelliffe-Pawlowski LL, Walton-Haynes L, Currier RJ. 2008. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results. Am J Med Genet A 146A(19):2455-2467.
15. Kiran TS, Bethel J, Bhal PS. 2005. Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome. J Obstet Gynecol 25(3): 253-256.
16. Lai YT, Beason KB, Brames GP, et al. 2000. Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation. Dev Biol 222(1): 1-11.
17. Loffredo CA. 2000. Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Genet 97(4): 319-325.
18. Malik S, Cleves MA, Honein MA, et al. 2008. Maternal smoking and congenital heart defects. Pediatrics 121(4): e810-e816.
19. Malik S, Cleves MA, Zhao W, Correa A, Hobbs CA. 2007. Association between congenital heart defects and small for gestational age. Pediatrics 119(4): e976-e982.
20. Muller F, Sault C, Lemay C, Roussel-Mizon N, Forestier F, Frendo JL. 2002. Second trimester two-step trisomy 18 screening using maternal serum markers. Prenat Diagn 22(7): 605-608.
21. Pradat P, Francannet C, Harris JA, Robert E. 2003. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol 24(3): 195-221.
22. Resta R, Luthy DA. 1991. Low AFP and congenital diaphragmatic defects. Am J Med Genet 40(1): 129.
23. Souter VL, Nyberg DA, El Bastawissi A, Zebelman A, Luthhardt F, Luthy DA. 2002. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21. Prenat Diagn 22(3): 175-182.
24. Verheijen PM, Lisowski LA, Stoutenbeek P, et al. 2001. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Thorac Cardiovasc Surg 121(4): 798-803.
25. Witters I, Legius E, Devriendt K, et al. 2001. Pregnancy outcome and long term prognosis in 868 children born after second trimester amniocentesis for maternal serum positive triple test screening and normal prenatal karyotype. J Med Genet 38(5): 336-338.
26. Witters I, Moerman P, Van Assche A, Fryns JP. 2002. Physical and psychomotor development of 1799 children born after second trimester amniocentesis for maternal serum positive triple test screening and normal prenatal karyotype. J Med Genet 39(12): e75.